David R. Janero

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Focused structure-activity relationship profiling around the 2-phenylindole scaffold of a cannabinoid type-1 receptor agonist-positive allosteric modulator: site-III aromatic-ring congeners with enhanced activity and solubility”.

Focused structure-activity relationship profiling around the 2-phenylindole scaffold of a cannabinoid type-1 receptor agonist-positive allosteric modulator: site-III aromatic-ring congeners with enhanced activity and solubility

Bioorganic & Medicinal Chemistry(2020)10.1016/j.bmc.2020.115727

N/A

0DataRank · unranked

9 citations

Pushkar M. Kulkarni, David R. Janero, Ganesh A. Thakur, Peter C. Schaffer

Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure

Bioorganic & Medicinal Chemistry(2021)10.1016/j.bmc.2021.116421

N/A

0DataRank · unranked

11 citations

Peter C. Schaffer, Robert B. Laprairie, David R. Janero, Roger G. Pertwee, Alex Straiker +2 more